Yeah, thats right TDA. Ever sector is different, but on balance, you'll never make money in the biotech space by buying and holding. These businesses just dont support LT investment, even with sophs as backers.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor